GEODE CAPITAL MANAGEMENT, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 46 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$7,890
-99.9%
8,905,936
+25.3%
0.00%
-50.0%
Q3 2022$11,160,000
-19.4%
7,108,284
+3.1%
0.00%0.0%
Q2 2022$13,854,000
+19.2%
6,892,947
+38.2%
0.00%
+100.0%
Q1 2022$11,618,000
-52.9%
4,986,433
-5.9%
0.00%
-66.7%
Q4 2021$24,650,000
-36.1%
5,301,256
+4.8%
0.00%
-40.0%
Q3 2021$38,602,000
-9.6%
5,059,333
+14.8%
0.01%
-16.7%
Q2 2021$42,693,000
+27.3%
4,405,946
+8.7%
0.01%
+20.0%
Q1 2021$33,529,000
+35.3%
4,054,313
+11.7%
0.01%
+25.0%
Q4 2020$24,783,000
-29.1%
3,631,241
+15.9%
0.00%
-42.9%
Q3 2020$34,945,000
+128.3%
3,134,150
+28.6%
0.01%
+133.3%
Q2 2020$15,305,000
+354.4%
2,437,121
+33.1%
0.00%
+200.0%
Q1 2020$3,368,000
-70.9%
1,830,666
-46.5%
0.00%0.0%
Q4 2019$11,560,000
+246.5%
3,420,428
+119.4%
0.00%0.0%
Q3 2019$3,336,000
-14.2%
1,558,926
+7.0%
0.00%0.0%
Q2 2019$3,890,000
-38.5%
1,457,029
+9.5%
0.00%
-50.0%
Q1 2019$6,321,000
+25.3%
1,330,747
-36.7%
0.00%
+100.0%
Q4 2018$5,044,000
+15.7%
2,101,760
+112.2%
0.00%0.0%
Q3 2018$4,358,000
-21.6%
990,620
+28.3%
0.00%
-50.0%
Q2 2018$5,560,000
+119.6%
772,318
+57.0%
0.00%
+100.0%
Q1 2018$2,532,000
+44.7%
491,776
+6.8%
0.00%0.0%
Q4 2017$1,750,000
+123.5%
460,6200.0%0.00%
Q3 2017$783,000
-2.7%
460,620
+14.3%
0.00%
Q2 2017$805,000
-44.4%
402,985
+9.8%
0.00%
-100.0%
Q1 2017$1,449,000
-16.3%
366,928
+3.8%
0.00%0.0%
Q4 2016$1,731,000
-36.6%
353,433
+0.2%
0.00%0.0%
Q3 2016$2,729,000
+152.5%
352,673
+82.7%
0.00%0.0%
Q2 2016$1,081,000
+9.6%
193,045
+5.3%
0.00%0.0%
Q1 2016$986,000
-36.3%
183,319
+3.0%
0.00%0.0%
Q4 2015$1,549,000
-4.8%
177,941
-8.3%
0.00%0.0%
Q3 2015$1,627,000
-54.8%
193,996
-5.0%
0.00%
-50.0%
Q2 2015$3,596,000
+183.6%
204,099
+86.1%
0.00%
+100.0%
Q1 2015$1,268,000
+15.8%
109,700
+0.9%
0.00%0.0%
Q4 2014$1,095,000
+182.9%
108,745
+26.9%
0.00%
Q3 2014$387,000
-31.5%
85,686
+2.3%
0.00%
Q2 2014$565,000
-13.6%
83,724
+63.9%
0.00%
Q1 2014$654,00051,0690.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders